California Healthcare Institute, BayBio, Biocom and CONNECT Statement on Reintroduction of the Innovation Act

Today. California Healthcare Institute, BayBio, Biocom and CONNECT issued the following joint statement regarding the introduction of patent litigation reform legislation – H.R. 9, the Innovation Act – in the U.S. House of Representatives this week. This statement may be attributed to Sara Radcliffe, President & CEO, CHI; Gail Maderis, President & CEO, BayBio; Joe Panetta, President & CEO, Biocom; and Greg McKee, CEO, CONNECT.